Stomach Cancer

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
BACKGROUND: Gastrectomy with D2 lymphadenectomy is the standard treatment for curable gastric cancer in eastern Asia.

Tokyo, Japan
Japan
[The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination
Many different chemotherapeutic modalities have been done for patients with peritoneal dissemination of gastric cancer.

Fukui, Japan
Japan
Determinants of surgical morbidity in gastric cancer treatment
BACKGROUND: The occurrence of early surgical complications after gastrectomy as a treatment for gastric cancer has been reported to have a negative impact on longterm survival.

Rome, Italy
Italy
Gastrointestinal stromal tumors: epidemiology, clinical picture, diagnosis, prognosis and treatment
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract.

Lublin, Poland
Poland
Laparoscopic gastric gastrointestinal stromal tumor resection: the Mayo Clinic experience
HYPOTHESIS: Laparoscopic resection of gastric gastrointestinal stromal tumors (GISTs) is safe and effective.
5777 E Mayo Blvd
Phoenix, AZ 85054
USA
Gastric fundic gland polyps and colonic polyps - is there a link, really?
BACKGROUND AND AIM: A retrospective analysis of endoscopic investigation was carried out.

Ludwigshafen, Germany 67063
Germany
Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic ga
OBJECTIVES: A phase II study of weekly paclitaxel combined with S-1, a novel oral fluoropyrimidine, was performed to evaluate the efficacy and tolerability in unresectable or metastatic gastric cancer.

Hiroshima, Japan
Japan
Gastric cancer stem cells
Cancer stem cells are defined as the unique subpopulation in the tumors that possess the ability to initiate tumor growth and sustain self-renewal as well as metastatic potential.

New York, NY 10032
USA
Food group intake and risk of subtypes of esophageal and gastric cancer
Incidence rates for adenocarcinomas of the esophagus and gastric cardia have been increasing rapidly, while rates for non-cardia gastric adenocarcinoma and esophageal squamous cell carcinoma have declined.

Montclair, NJ 07043
USA
[Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum]
Neuroendocrine tumors (NETs) are relatively rare and comprise carcinoids, gastrinomas, and poorly differentiated endocrine carcinomas (PDECs). pa

Tokyo, Japan
Japan